The ER+ MCF-7 breast cancer cell line shows a strong growth response to IGF-I, while the ER- MDA-MB-468 breast cancer cell line does not respond to IGF-I-induced growth stimulation. The gene discussed is ESR1; the disease is breast carcinoma.